scispace - formally typeset
B

Balasubramanian Manickam

Researcher at Pfizer

Publications -  5
Citations -  47

Balasubramanian Manickam is an academic researcher from Pfizer. The author has contributed to research in topics: Mononuclear phagocyte system & Lung. The author has an hindex of 2, co-authored 5 publications receiving 17 citations.

Papers
More filters
Journal ArticleDOI

Nanoparticle contrast-enhanced micro-CT: A preclinical tool for the 3D imaging of liver and spleen in longitudinal mouse studies

TL;DR: ExiTron nano12000 contrast agent-enhanced micro-CT could be used as a safe method in up to 29-day longitudinal efficacy and toxicology mouse studies for the non-invasive assessment of the liver and spleen.
Journal ArticleDOI

In silico approaches in carcinogenicity hazard assessment: Current status and future needs

TL;DR: The current status of in silico tools for the assessment of each KC is summarized and the data gaps that need to be addressed are identified before a comprehensive insilico carcinogenicity protocol can be developed for regulatory use.
Journal ArticleDOI

Automated monitoring of respiratory rate as a novel humane endpoint: A refinement in mouse metastatic lung cancer models.

TL;DR: In this paper, the authors identify objective non-invasive criteria for predicting imminent distress and mortality in metastatic lung tumor-bearing mice and propose that increases in respiratory rate (1.3-1.5 X) can be used to provide an objective benchmark to signal the need for increased clinical observations or euthanasia.
Journal ArticleDOI

Behavioral, Histopathologic, and Molecular Biological Responses of Nanoparticle- and Solution-Based Formulations of Vincristine in Mice.

TL;DR: It is suggested that the nano-VCR formulation may alleviate behavioral changes in CiPN, but it does not improve the structural changes of CiPN in peripheral nerve.